beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1) (Middle Region) Peptide
B4GALNT1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN973689
Quick Overview for beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1) (Middle Region) Peptide (ABIN973689)
Target
B4GALNT1
(beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- GLGSLRVGSC SDVVVDHASK LKLPWTSRDA GAETYARYRY PGSLDESQMA
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-B4GALNT1 Antibody(ARP45118_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- B4GALNT1 (beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1))
-
Background
-
GM2 and GD2 gangliosides are sialic acid-containing glycosphingolipids. GalNAc-T is the enzyme involved in the biosynthesis of G(M2) and G(D2) glycosphingolipids. B4GALNT1(GalNAc-T) catalyzes the transfer of GalNAc into G(M3) and G(D3) by a beta-1,4 linkage, resulting in the synthesis of G(M2) and G(D2), respectively.
Alias Symbols: GALGT, GALNACT
Protein Interaction Partner: B4GALNT1,B4GALNT1
Protein Size: 533 -
Molecular Weight
- 59 kDa
-
Gene ID
- 2583
-
NCBI Accession
- NM_001478, NP_001469
-
UniProt
- Q00973
Target
-
You are here:
